(Q51074226)

28 March 2018

title

Negative affectivity, restriction of emotions, and site of metastases predict mortality in recurrent breast cancer. (English)

1 reference

28 March 2018

author

Samuel J. Simmens

3

1 reference

28 March 2018

author name string

Weihs KL

1

1 reference

28 March 2018

Enright TM

2

1 reference

28 March 2018

Reiss D

4

1 reference

28 March 2018

publication date

1 July 2000

1 reference

28 March 2018

Journal of Psychosomatic Research

published in

1 reference

28 March 2018

volume

49

1 reference

28 March 2018

issue

1

1 reference

28 March 2018

page(s)

59-68

1 reference

28 March 2018

Survival hazards analysis in first recurrent breast cancer patients: seven-year follow-up

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Do psychological factors predict survival in breast cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Life events and breast cancer prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

The prognostic significance of psychosocial factors in women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Social relations, social support and survival among patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Quality of life in stage II breast cancer: an instrument for clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Psychological Coping Mechanisms and Survival Time in Metastatic Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Psychogenic factors in predicting survival of breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Psychobiological factors predicting the course of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

The connection between the psychological condition of breast cancer patients and survival. A follow-up after eight years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Psychosocial factors in breast cancer and their possible impact upon prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

A biobehavioral model of cancer stress and disease course

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

7 January 2021

Emotional control and autonomic arousal in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Clinical relevance of the Marlowe-Crowne Scale: a review and recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Psychosocial intervention with cancer patients: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

The development of a short form of the manifest anxiety scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Negative affectivity: the disposition to experience aversive emotional states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Styles of inhibiting emotional expression: distinguishing repressive coping from impression management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Coping as a mediator of emotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Coping strategies and course of disease of breast cancer patients. Results of a 3-year longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Are coping strategies related to disease outcome in early breast cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Profile of Mood States: Australian normative data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Subscales to the Taylor Manifest Anxiety Scale in three chronically ill populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Internal-external control, defensiveness, and anxiety in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Symptom reporting in cancer patients: the role of negative affect and experienced social stigma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

The relationship between repressive and defensive coping styles and monocyte, eosinophile, and serum glucose levels: support for the opioid peptide hypothesis of repression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Emotional repression, stress disclosure responses, and Epstein-Barr viral capsid antigen titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Physiologic and psychobehavioral research in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Group therapy and hypnosis reduce metastatic breast carcinoma pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Effect of psychosocial treatment on survival of patients with metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

Psychological response to cancer and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

7 January 2021

A personality scale of manifest anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

7 January 2021

Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

7 January 2021

Ambivalence and defense: effects of a repressive style on normal adolescents' and young adults' mixed feelings

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

7 January 2021

Individual differences in repressive-defensiveness predict basal salivary cortisol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900143-4

7 January 2021

10.1016/S0022-3999(00)00143-4

Identifiers

DOI

1 reference

28 March 2018

1 reference

28 March 2018